Capital City Trust CO Stryker Corp Transaction History

Capital City Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	BUY	$253.85 - $299.46 $176,933 - $208,723	697 New	697 $208,000
Q1 2023 Apr 19, 2023	BUY	$246.13 - $285.47 $7,383 - $8,564	30 Added 3.62%	858 $244,000
Q4 2022 Jan 27, 2023	SELL	$205.51 - $253.93 $76,038 - $93,954	-370 Reduced 30.88%	828 $0
Q2 2022 Jul 15, 2022	SELL	$194.09 - $276.37 $388 - $552	-2 Reduced 0.17%	1,198 $238,000
Q1 2022 Apr 20, 2022	BUY	$245.33 - $277.77 $9,813 - $11,110	40 Added 3.45%	1,200 $321,000
Q2 2021 Jul 23, 2021	BUY	$242.95 - $267.0 $281,822 - $309,720	1,160 New	1,160 $301,000
Q2 2020 Jul 15, 2020	SELL	$144.67 - $207.03 $189,517 - $271,209	-1,310 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$126.5 - $225.1 $165,715 - $294,881	1,310 New	1,310 $218,000

2,171

286M

1.13M

1.1M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Capital City Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital City Trust CO with notifications on news.